were compared for subchronic toxicity by feeding F344 rats and BDF 1 mice of both sexes p-CNB-or o-CNB-containing diets at 5 different concentrations for 13 weeks. The two isomers induced hematotoxicity and hepatotoxicity of different toxic potencies. p-CNB produced an anemic sign of external appearance in rats and mice, while o-CNB did not. Significant increases in the incidences of increased erythropoiesis in the bone marrow and increased extramedullary hematopoiesis in the spleen and liver, and in serum total bilirubin in rats and mice appeared at lower dose levels of p-CNB than o-CNB. A significant increase in serum ALT activity appeared at lower dose levels of o-CNB than p-CNB, together with appearance of both necrosis and hydropic degeneration of hepatocytes only in the o-CNB-fed rats and nuclear enlargement with atypia of hepatocytes only in the o-CNB-fed mice. BMDL 10S of p-and o-CNB for the hematotoxic endpoint, substitutes for NOAELs, were 0.177 mg/kg/day and 1.03 mg/kg/day for the rats, respectively. For the mice, the NOAELs of p-and o-CNB for the hematotoxic endpoint were 10.5 mg/kg/day and 10.4 mg/kg/day, respectively. A NOEL of o-CNB for the hepatotoxic endpoint resulted in 13.8 mg/kg/day for the rats and 12.2 mg/kg/day for the mice. These results suggest that p-CNB is a more potent hematotoxicant than o-CNB, whereas o-CNB is a more potent hepatotoxicant than p-CNB, and that the rat hematopoietic system is more susceptible to p-CNB than the mouse hematopoietic system.
INTRODUCTION
Para-chloronitrobenzene (p-CNB) and orthochloronitrobenzene (o-CNB) have been used primarily as chemical intermediates in the manufacture of drugs, dyes, rubber preservatives and photographic chemicals (NIOSH/OSHA 1978) . The estimated annual production figures of o-and p-CNB in 1985 were 60,000 tons in Germany, 40,000 tons in the U.S.A. and 30,000 tons in Japan (IARC, 1996) . The annual production of p-CNB in Japan was 15,000 tons in 2002 (Chemical Daily, 2004) . Exposure of workers to p-CNB was reported to cause methemoglobinemia, along with headache, vertigo and cyanosis (Renshaw and Ashcroft, 1926; Saita and Moreo, 1958; Pacséri et al.,1958; Tabuchi et al., 1985) . A total of 52 workers suffered from acute poisoning by aromatic chloro-and nitro-compounds in Japan from 1956 to 1985 (Ishizu, 1994) . Some experimental studies showed that inhalation exposure of experimental animals to chloronitrobenzenes produced methemoglobin and microscopic changes in the spleen (Nair et al., 1986a and 1986b) as well as methemoglobinemia and a variety of tissue changes secondary to oxidative erythrocyte injury (NTP, 1993; Travlos et al., 1996) . However, there is a paucity of subchronic toxicity data for orally administered chloronitrobenzenes, although a few acute toxicity data by the single administration of p-or o-CNB through the oral, subcutaneous or intraperitoneal route have been reported (Hasegawa and Sato, 1963; Watanabe et al., 1976; Ridley et al., 1983; Yoshida et al., 1991 and 1993) . The American Conference of Governmental Industrial Hygienists (ACGIH, 2001 ) and the Japan Society for Occupational Health (JSOH, 1989) recommended an occupational exposure limit of 0.1 ppm only for p-CNB. However, an occupational exposure limit of o-CNB has not yet been published. Since fewer toxicity data are available for o-CNB than for p-CNB, understanding the differential toxicity of chloronitrobenzene isomers is important for risk characterization.
The present study was intended to characterize differences in subchronic toxicity between p-and o-CNB, and to understand the dose-response relationships of some important toxicity parameters for the health risk assessment of humans exposed to p-or o-CNB or both in the workplace and the living environment. The subchronic toxicity of p-and o-CNB was examined by feeding F344 rats and BDF 1 mice of both sexes p-and o-CNB-containing diets at 5 different concentrations for 13 weeks.
MATERIALS AND METHODS
This study was conducted in accordance with the Organisation for Economic Co-operation and Development (OECD) Good Laboratory Practice (OECD, 1981a) and with reference to the OECD Guideline for Testing of Chemicals 408 "Subchronic Oral ToxicityRodent: 90-day Study" (OECD, 1981b) . This study was approved by the ethics committee of the Japan Bioassay Research Center.
Chemicals
p-and o-CNB of guaranteed grade (greater than 99% pure) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). The p-and o-CNB were analyzed for stability and purity by mass spectrometry and infrared spectrometry. Neither decomposition products nor impurities were detected in the test substance before or after use.
Animals
Four-week-old F344/DuCrj rats (SPF) and Crj:BDF 1 mice (SPF) of both sexes were obtained from Charles River Japan, Inc. (Kanagawa, Japan). In each study of p-or o-CNB, the animals were quarantined and acclimated for 2 weeks, and then divided by stratified randomization into 6 body weight-matched groups, each comprising 10 rats and 10 mice of both sexes. relative humidity of 54 ± 5% with 15 to 17 air changes/ hr) in barrier system animal rooms. Fluorescent lighting was controlled automatically to give a 12-hr light/ dark cycle. All animals had free access to filtered, UVirradiation-sterilized water supplied by an automatic watering system. They were also given a control diet or a p-or o-CNB-containing diet at 5 different concentrations ad libitum during the 13-week administration period, starting at the age of 6 weeks.
Diet preparation and feeding
A diet containing p-or o-CNB was prepared by blending p-or o-CNB with γ-irradiation-sterilized powdered diet (CRF-1, Oriental Yeast Co., Tokyo, Japan) in a spiral mixer. The dietary concentrations of p-and o-CNB were determined on the basis of our preliminary 2-week oral administration studies of p-and o-CNB. In the p-CNB study, the rats were fed 24.7, 74.1, 222, 667 or 2000 ppm (w/w), and the mice were fed 74.1, 222, 667, 2000 or 6000 ppm (w/w). In the o-CNB study, the rats were fed 63, 250, 1000, 2000 or 4000 ppm (w/w), and the mice were fed 78, 313, 1250, 2500 or 5000 ppm (w/w). The powdered diets containing p-CNB were prepared once a week. The o-CNBcontaining diets were prepared 2 times at an interval of 7 weeks, and stored at 4°C until use during the 13-week administration period. The feeder containing the p-or o-CNB-containing or control diet in the individual cage was exchanged once a week. The concentrations of p-or o-CNB in the powdered diet were determined by gas chromatography, and were found to range from 79.3% to 103% for p-CNB and 96.0% to 101% for o-CNB compared to the target concentrations at the time of preparation, and to decrease to 74.6% to 86.1% for p-CNB and 80.4% to 88.9% for o-CNB 8 days after preparation, when the initial observed concentrations were taken as 100%.
Clinical observations and analysis, and pathologic examinations
The animals were observed daily for clinical signs and mortality. Body weight and food consumption were recorded once a week. Daily food consumption was calculated by subtracting the weight of the remaining diet from that of the initial diet and dividing by feeding days. Daily intake of p-and o-CNB were calculated from the daily amount of the consumed food, multiplied by the time-averaged, observed concentration of p-and o-CNB in the diet, respectively, and divided by the body weight and expressed as mg/ kg/day. All animals underwent complete necropsy. The Vol. 31 No. 1 organs were removed, weighed and examined for macroscopic lesions at necropsy. Blood was collected for hematology and blood biochemistry under etherization after overnight fasting at the end of the 13-week administration period. Hematological parameters were measured with an Automatic Blood Cell Analyzer (Coulter Counter SP, Coulter Electronics Inc., U.S.A. for p-CNB, and ADVIA120, Bayer Corp., Germany for o-CNB). Blood biochemical parameters were measured with an Automatic Analyzer (Hitachi 705 for p-CNB and 7070 for o-CNB, Hitachi Ltd., Japan). The tissues specified in the OECD test guideline (OECD, 1981b) were examined for histopathology. For microscopic examinations, the tissues were fixed in 10% neutral buffered formalin, and were embedded in paraffin. Tissue sections of 5 µm thick were prepared, and were stained with hematoxylin and eosin (H & E). The lesions were diagnosed with reference to the literature, "Pathology of the Fischer Rats" (Stefanski et al., 1990) and "Pathology of the Mouse" (Ward et al., 1999) .
Statistics, NOAEL, NOEL and benchmark dose
Body weights, organ weights, and hematological and blood biochemical parameters were analyzed by the following algorism (Yamazaki et al., 1981; Hamada et al., 1998) . Bartlett's test was used to test whether the variance was homogeneous or not. When variance was homogeneous, one-way ANOVA was performed. When variance was not homogeneous, the Kruskal-Wallis rank sum test was performed by arranging all data of the control and exposed groups in descending order. Statistical differences in the means and the rank means among the groups were analyzed by Dunnett's multiple comparison test (Dunnett, 1964) , and the same multiple comparison test by rank, respectively. Histopathologic findings were analyzed by Fisher's exact test (Fisher,1973) . A two-sided analysis with p-values of 0.05 and 0.01 was performed to determine statistical significance.
A no-observed-adverse-effect-level (NOAEL) and a no-observed-effect-level (NOEL) were determined for both the rats and the mice of either sex according to the WHO definition (IPCS, 1994) .
When any NOAEL could not be determined because the most sensitive and biologically significant parameter attained statistical significance at the lowest dose level, a benchmark dose approach was used. The confidence limits of the benchmark dose yielding a response with a 10% extra risk (BMDL 10 ) were calculated for the dataset, using the software of BMDS Version 1.3.2 downloaded from US.EPA's NCEA website (US.EPA, 2001) . A best-fit benchmark dose model was chosen among various models including Linear, Polynomial, Power and Hill, based on a goodness-of-fit pvalue greater than 0.05 and the lowest Akaike's Information Criterion (AIC) value among the models. The model fitting to a plotted curve between the doses as daily chemical intakes and the responses or incidences was also visually inspected.
RESULTS

Clinical signs, body and organ weights
A 6000 ppm p-CNB-fed female mouse and a 1250 ppm o-CNB-fed female mouse died during the 13-week administration period. In the p-CNB study, all the male and female rats fed 667 ppm and above and all male and female mice fed 2000 and 6000 ppm exhibited an anemic sign of external appearance, as manifested by discolored and pale skin, eyes and ears. However, there was no anemic sign of external appearance in any of the rats or mice of either sex fed o-CNB.
Among the highest-dosed groups of the rats and mice of both sexes fed p-and o-CNB, the terminal body weights of the 6000 ppm p-CNB-fed male mice and the 4000 ppm o-CNB-fed male and female rats were significantly decreased by 10% or more, compared with the respective controls.
The relative spleen and liver weights of the rats and mice of both sexes were linearly increased with an increase in dietary concentration of p-or o-CNB (Fig.  1) . Notably, the spleen weights of the rats and mice responded with steeper slopes to p-CNB than to o-CNB, whereas the liver weights of the rats and mice responded more steeply to o-CNB than to p-CNB.
The estimated amounts of p-and o-CNB intake corresponding to the dietary concentrations of p-and o-CNB are given Tables 1 and 2 .
Hematology
In the p-CNB study, the most sensitive and statistically significant change in the hematological parameter was a decrease in red blood cell counts (RBC) for the female rats fed 24.7 ppm and a decrease in RBC with a concomitant increase in MCV for the female mice fed 667 ppm (Table 1 ). In the o-CNB study, the most sensitive, significant hematological change was a decrease in RBC and hemoglobin for the female rats fed 63 ppm and a decrease in MCV for the female mice fed 313 ppm ( Table 2) . The RBC and MCV responses to 2000 ppm p-CNB, as manifested by a decrease in RBC and a concomitant increase in MCV, were greater in magnitude than those to 2000 ppm o-CNB, indicating that the p-CNB-induced erythrocyte injury was more severe than that induced by o-CNB.
Blood biochemistry
In the p-CNB study, serum total bilirubin was significantly increased in the male and female rats fed 667 ppm and above, and in the male and female mice fed 6000 ppm (Table 1 ). In the o-CNB study, serum total bilirubin was significantly increased in the male rats fed 1000 ppm and above, in the female rats fed 2000 and 4000 ppm and in the female mice fed 5000 ppm (Table 2 ). In the p-CNB study, AST was increased only in the male rats fed 2000 ppm, and both AST and ALT were significantly increased in the male and female mice fed 6000 ppm (Table 1 ). In the o-CNB study, significant increases in AST and ALT for the rats of both sexes and a significant increase only in ALT for the mice of both sexes were noted at different dose levels.
Histopathology 1) Bone marrow
In the p-CNB study, a significantly increased incidence of increased erythropoiesis in the bone marrow was noted in the male and female rats fed 222 ppm and above and in the male and female mice fed 2000 and 6000 ppm (Table 3 ). Hemosiderin deposition in the 40.7 ± 1.4 ** 39.4 ± 1.0 ** 40.8 ± 1.3 ** 41.7 ± 1.4 * 42.8 ± 1.4 43.3 ± 1.5 Hematocrit (%) 75.2 ± 2.3 ** 54.9 ± 1.3 ** 48.8 ± 0.6 ** 46.9 ± 0.4 46.0 ± 0.2 45.8 ± 0.4 MCV (fL) 0.47 ± 0.06 ** 0.23 ± 0.03 * 0.16 ± 0.02 0.14 ± 0.01 0.14 ± 0.02 0.15 ± 0.02 Total bilirubin (mg/dL) 77 ± 13 ** 60 ± 8 64 ± 12 65 ± 9 65 ± 10 64 4.58 ± 0.26 ** 5.93 ± 0.18 ** 7.29 ± 0.22 ** 7.94 ± 0.16 ** 8.42 ± 0.34 * 8.75 ± 0.38 Red blood cell (10 6 /µL) 13.8 ± 0.2 ** 13.9 ± 0.3 ** 14.3 ± 0.4 ** 15.0 ± 0.3 15.6 ± 0.5 15.9 ± 0.6 Hemoglobin (g/dL)
40.6 ± 1.1 36.4 ± 4.3 ** 38.9 ± 1.1 ** 40.5 ± 1.0 41.8 ± 1.6 42.7 ± 1.8 Hematocrit (%) 88.8 ± 0.4 ** 61.2 ± 6.4 ** 53.3 ± 0.5 ** 51.0 ± 0.4 49.6 ± 0.2 48.8 ± 0.3 MCV (fL) 0.58 ± 0.05 ** 0.36 ± 0.06 ** 0.23 ± 0.02 0.19 ± 0.04 0.20 ± 0.04 0.19 ± 0.02 Total bilirubin (mg/dL) 67 ± 4 61 ± 11 60 ± 5 62 ± 9 65 ± 11 58 ± 4 AST (IU/L) 13 ± 1 ** 15 ± 3 18 ± 4 21 ± 6 22 ± 6 18 ± 3 ALT (IU/L) 38.8 ± 3.9 ** 39.2 ± 1.3 ** 43.4 ± 1.7 43.7 ± 1.0 43.3 ± 1.6 44.0 ± 1.2 Hematocrit (%) 59.3 ± 3.7 ** 42.9 ± 0.4 ** 42.0 ± 0.7 41.0 ± 0.5 41.0 ± 0.5 41.2 ± 0.5 MCV (fL) 0.46 ± 0.05 ** 0.30 ± 0.13 0.29 ± 0.04 0.27 ± 0.05 0.31 ± 0.04 0.28 ± 0.03 Total bilirubin (mg/dL) 134 ± 71 ** 38 ± 7 40 ± 7 36 ± 5 37 ± 4 36 ± 3 AST (IU/L) 54 ± 46 ** 9 ± 2 11 ± 5 10 ± 2 9 ± 1 9 ± 2 ALT (IU/L) 36.8 ± 3.6 ** 37.6 ± 1.5 ** 42.2 ± 1.8 43.7 ± 1.7 44.0 ± 2.2 43.4 ± 1.4 Hematocrit (%) 59.5 ± 2.2 ** 43.2 ± 0.8 ** 42.9 ± 0.5 ** 42.0 ± 0.3 41.8 ± 0.5 41.6 ± 0.4 MCV (fL) 0.50 ± 0.10 ** 0.30 ± 0.05 0.29 ± 0.04 0.33 ± 0.07 0.33 ± 0.06 0.32 ± 0.03 Total bilirubin (mg/dL) 79 ± 15 ** 50 ± 8 46 ± 9 50 ± 9 47 ± 9 48 ± 8 AST (IU/L) 17 ± 2 ** 12 ± 2 11 ± 2 11 ± 2 11 ± 2 11 ± 2 ALT (IU/L) Mean ± S.D. * and **: Significant difference at p<0.05 and p<0.01 by Dunnett test, respectively. MCV: Mean corpuscular volume. AST: Aspartate aminotransferase. ALT: Alanine aminotransferase. − : The data could not be obtained because of incomplete hemolysis of the blood in the 2000 and 6000 ppm groups of mice. a) : The measurements could not be performed for 1 or 2 animals because of shortage of blood volume. b) : One animal died during the 13-week administration period. 44.1 ± 0.9 ** 45.0 ± 1.0 ** 47.0 ± 0.6 48.4 ± 1.1 49.1 ± 1.6 47.7 ± 1.0 Hematocrit (%) 45.5 ± 0.7 45.5 ± 0.6 46.2 ± 0.7 ** 45.8 ± 0.5 * 45.4 ± 0.7 45.0 ± 0.5 MCV (fL) 0.25 ± 0.07 ** 0.20 ± 0.05 0.17 ± 0.03 0.17 ± 0.01 0.17 ± 0.02 0.18 ± 0.02 Total bilirubin (mg/dL) 71 ± 32 54 ± 9 51 ± 13 54 ± 8 54 ± 14 56 ± 8 AST (IU/L) 65 ± 39 ** 51 ± 12 ** 32 ± 7 * 22 ± 2 21 ± 4 20 ± 2 ALT (IU/L) Mean ± S.D. * and **: Significant difference at p<0.05 and p<0.01 by Dunnett test, respectively. MCV: Mean corpuscular volume. AST: Aspartate aminotransferase. ALT: Alanine aminotransferase. − : The data could not be obtained because of incomplete hemolysis of the blood in the 2000 ppm groups of mice. a) : The measurements could not be performed for 1 animal because of shortage of blood volume. b) : One animal died during the 13-week administration period. bone marrow was observed only in the male and female mice fed 2000 and 6000 ppm. In the o-CNB study, a significantly increased incidence of erythropoiesis in the bone marrow was noted in the male and female rats fed 2000 and 4000 ppm, but not in any of the o-CNB-fed mice of either sex (Table 4) . Notably, the significantly increased incidence of increased erythropoiesis in the bone marrow of the rats and mice appeared at a lower dose level of p-CNB than at that of o-CNB.
2) Spleen
In the p-CNB study, a significantly increased incidence of congestion, hemosiderin deposition and increased extramedullary hematopoiesis were noted in the male and female rats fed 74.1 ppm and above and in the male and female mice fed 667 ppm and above (Table 3 ). In the o-CNB study, the incidence of congestion and hemosiderin deposition in the spleen was significantly increased in the male and female rats fed 250 ppm and above, and the incidence of increased extramedullary hematopoiesis in the spleen was increased in the male and female rats fed 1000 ppm and above (Table 4) . o-CNB significantly increased the incidence of congestion and increased exramedullary hematopoiesis in the male and female mice fed 1250 ppm and above, and the incidence of hemosiderin deposition in the male and female mice fed 313 ppm and above. Capsule hyperplasia was observed in the male and female rats fed 222 ppm p-CNB and above (Table  3) , and in the male and female rats fed 2000 and 4000 ppm o-CNB (Table 4) , but not in any of the p-or o-CNB-fed mice of either sex. Notably, the significantly increased incidence of capsule hyperplasia in the rat spleen appeared at a lower dose level of p-CNB than at that of o-CNB. The affected capsule was characterized by focal or multifocal fibrous thickenings, outward expansion of the capsule and the incorporation of hematopoietic cells (Photo 1). Capsule hyperplasia was more pronounced in the p-CNB-fed rats than in the o-CNB-fed rats.
3) Liver
In the p-CNB study, the incidence of hemosiderin deposition in Kupffer's cells was significantly increased in the male and female rats fed 222 ppm and above and in the male and female mice fed 2000 and 6000 ppm (Table 3 ). In the o-CNB study, the incidence of hemosiderin deposition in Kupffer's cells was significantly increased in the male and female rats fed 1000 ppm and above and in the male and female mice fed 1250 ppm and above (Table 4 ). In the p-CNB study, the incidence of increased extramedullary hematopoiesis in the liver was significantly increased in the male rats fed 667 and 2000 ppm, in the female rats fed 2000 ppm, in the male mice fed 6000 ppm and in the female mice fed 2000 and 6000 ppm. However, increased extramedullary hematopoiesis in the liver was not observed in any of the o-CNB-fed rats or mice of either sex.
In the p-CNB study, the incidence of centrilobular hypertrophy of hepatocytes was significantly increased in the male rats fed 2000 ppm, in the male mice fed 6000 ppm and in the female mice fed 2000 and 6000 ppm, but not in any of the p-CNB-fed female rats. In the o-CNB study, a significantly increased incidence of centrilobular hypertrophy of hepatocytes was noted in the male rats fed 2000 and 4000 ppm, in the female rats fed 4000 ppm, in the male mice fed 313 ppm and above and in the female mice fed 1250 ppm and above. o-CNB significantly increased the incidence of single cell necrosis in the male and female rats fed 1000 ppm and above, but not in any of the o-CNB-fed mice of either sex. On the other hand, the incidence of nuclear enlargement with atypia of centrilobular hepatocytes, which was characterized by cell enlargement, varying nuclear size and shape and coarse chromatin in the nucleus (Photo 2), was significantly increased only in the male mice fed 313 ppm o-CNB and above and in the female mice fed 1250 ppm and above, but not in any of the o-CNB-fed rats of either sex. The hydropic degeneration of the centrilobular hepatocytes, which was characterized by the ballooning of hepatocytes enriched with watery materials, occurred only in the male rats fed 1000 ppm and above and in the female rats fed 2000 and 4000 ppm. Notably, o-CNB produced both necrosis and hydropic degeneration in the rats and nuclear enlargement with atypia of centrilobular hepatocytes in the mice, while p-CNB did not.
DISCUSSION
In the present study, oral administration of p-CNB and o-CNB to rats and mice in feed for 13 weeks was found to induce hematotoxicity and hepatotoxicity, in which the toxic potencies of the two isomers were different from each other. The more pronounced potency of the hematotoxicity of p-CNB compared to o-CNB was evidenced from the following results: First, an anemic sign of external appearance was observed only in the p-CNB-fed rats and mice. Second, Table 3 . Number of animals of bone marrow, splenic and hepatic lesions of the rats and mice fed p-chloronitrobenzene-containing diets for 13 weeks. : One animal died in week 7.
Vol. 31 No. 1 Table 4 . Number of animals of bone marrow, splenic and hepatic lesions of the rats and mice fed o-chloronitrobenzene-containing diets for 13 weeks. the RBC and MCV responses to 2000 ppm p-CNB were greater in magnitude than those to 2000 ppm o-CNB. Third, a significantly increased incidence of bone marrow erythropoiesis and splenic extramedullary hematopoiesis was observed at lower dose levels of p-CNB than at those of o-CNB. Extramedullary hematopoiesis in the liver appeared only in the p-CNBfed animals. Fourth, magnitude of the increase in spleen weight was greater in the p-CNB-fed animals than in the o-CNB-fed animals. The appearance of the increased total bilirubin at lower dose levels of p-CNB than at those of o-CNB was considered to result from more pronounced erythrocyte injury to the p-CNB-fed animals than that to the o-CNB-fed animals.
On the other hand, the greater hepatotoxic potency of o-CNB compared to p-CNB was evidenced by the significantly increased serum ALT activity at lower dose levels of o-CNB in the rats and mice than at those of p-CNB, the necrosis and hydropic degeneration of hepatocytes in the o-CNB-fed rats, and the nuclear enlargement with atypia of hepatocytes in the o-CNB-fed mice. The o-CNB-induced increase in serum ALT activity was considered to reflect the cytolytic release of liver-associated transaminase into serum, resulting from the necrotic and degenerative responses of hepatocytes to o-CNB. The present findings of the potent hematotoxicity of p-CNB over o-CNB could plausibly be elucidated in terms of the findings of prior studies that p-CNB was a stronger methemoglobin inducer than o-C NB Photo 1. Capsule hyperplasia (double-headed arrows), extramedullary hematopoiesis (arrows) and congestion (arrow heads) of the spleen in a male rat fed 667 ppm p-CNB for 13 weeks (left) and in a male rat fed 2000 ppm o-CNB for 13 weeks (right). Note that the capsule hyperplasia was more pronounced in the p-CNB-fed rat than in the o-CNB-fed rat. H & E stain. Bars indicate 100 µm.
Vol. 31 No. 1 (Watanabe et al., 1976; Nair et al., 1986a and 1986b; NTP, 1993; Travlos et al., 1996) . The increases in bone marrow erythropoiesis and splenic extramedullary hematopoiesis found in the present study were considered to reflect the compensatory responses of the hematopoietic system to erythrocyte injury presumably resulting from methemoglobin formation, which underwent hemolysis and hemosiderosis in splenic macrophages and hepatic Kupffer's cells. The present findings of the more potent hepatotoxicity of o-CNB compared to p-CNB seemed to be different from the results by Nair (1986b) , who reported that the most remarkable toxic effect of o-CNB was its effect on the hematopoietic system in the absence of microscopic changes in the liver and that the hematotoxicity of o-CNB was similar to that of p-CNB. In contrast to the reported absence of overt hepatotoxicity of o-CNB (Nair et al., 1986b) , the potent o-CNB-induced hepatotoxicity found in the present study was evidenced by the increased incidence of single cell necrosis and hydropic degeneration in rats, the cytolytic release of liver-associated ALT into serum in the rats and mice and the nuclear enlargement with atypia of centrilobular hepatocytes in the mice. These hepatic lesions indicated toxicity arising from parenchymal hepatocytes, but not from the hepatic sinusoid in which the injured erythrocytes were scavenged by Kupffer's cells, resulting in hepatic hemosiderin deposition. The present findings of the oral subchronic toxicity of the two isomers were essentially consistent Photo 2. Hemosiderin deposition in Kupffer's cells (arrow) in a male mouse fed 6000 ppm p-CNB for 13 weeks (left) and centrilobular hypertrophy of hepatocytes accompanied by nuclear enlargement with atypia, varying nuclear size and shape and coarse chromatin in the nucleus (arrows) in a male mouse fed 5000 ppm o-CNB for 13 weeks (right). H & E stain. Bars indicate 100 µm.
with the hematotoxicity and hepatotoxicity induced by 13-week inhalation exposure to p-and o-CNB vapor of F344 rats and B6C3F 1 mice of both sexes for 13 weeks (Travlos et al., 1996) , although there was a difference in the route of administration between the two studies. They reported that hepatocellular hypertrophy (mice), cytoplasmic basophilia (rats) and liver necrosis (mice) were specifically induced by the inhalation of o-CNB, in addition to a variety of microscopic changes in the erythrocytes, spleen and liver, all of which were secondary to the methemoglobin-induced erythrocyte injury. They also suggested that o-CNB-induced hepatotoxicity was attributable to the decreased oxygencarrying capacity of the injured RBC, resulting in hepatocellular hypoxia. However, this is unlikely in the present study because the necrosis and hydropic degeneration of hepatocytes and the cytolytic release of liver-associated ALT into serum occurred in the female rats fed 2000 ppm o-CNB, while neither histopathological or biochemical lesions of the parenchymal hepatocytes were induced in the female rats fed 2000 ppm p-CNB, which would be a stronger methemoglobin inducer than 2000 ppm o-CNB. The NOAELs of p-and o-CNB could not be determined for the rats of either sex, since the most sensitive parameter of the decreased RBC attained statistical significance at the lowest dietary concentrations of 24.7 ppm p-CNB and 63 ppm o-CNB in the female rats. Instead, we were able to use a benchmark dose approach that has advantages over the NOAEL/ LOAEL approach by using all sets of the experimental data to delineate a dose-response relationship (US.EPA, 2001), thereby allowing estimation of the corresponding NOELs or NOEL within a factor of 2 to 3-fold (Allen et al., 1994; Senoh et al., 2003) . In the present study, the benchmark dose approach using the Hill model was successfully applied to the doseresponse relationships between the daily chemical intakes calculated from dietary concentrations and body weights of p-and o-CNB and the RBCs for the female rats. The BMDL 10 values of p-and o-CNB for the hematotoxic endpoint were 0.177 mg/kg/day and 1.03 mg/kg/day for the rats, respectively. For the mice, the NOAELs represented as chemical intake of p-and o-CNB for the hematotoxic endpoint were 10.5 mg/kg/ day and 10.4 mg/kg/day, respectively, since the most sensitive parameter of splenic hemosiderin deposition attained statistical significance at 36.7 mg/kg/day p-CNB and 43.6 mg/kg/day of o-CNB. These results suggested that for both rats and mice, p-CNB was more sensitive to erythrocyte injury than o-CNB, and that the rat hematopoietic system was more susceptible to p-CNB than the mouse hematopoietic system.
In addition to the NOAELs for the hematotoxic endpoint, a NOEL of o-CNB for the hepatotoxic endpoint can be determined for rats and mice of either sex. Both the necrosis/hydropic degeneration of hepatocytes occurring in the male rats fed 57.5 mg/kg/day o-CNB and the hepatocellular hypertrophy accompanied by nuclear enlargement with atypia occurring in the male mice fed 43.6 mg/kg/day o-CNB were presumably attributable not to a secondary effect of the decreased oxygen-carrying capacity of injured RBC but to a possible direct action of o-CNB on hepatocytes. The reason for this was that these histopathological changes in the liver did not occur at the same dietary concentrations of the more potent hematotoxicant, p-CNB. Therefore, a NOEL of o-CNB for the hepatotoxic endpoint resulted in 13.8 mg/kg/day for the rats and 12.2 mg/kg/day for the mice, both of which were higher than the BMDL 10 value of 1.03 mg/kg/day o-CNB for the hematotoxic endpoint. However, the NOEL of p-CNB for the same hepatotoxic endpoint in rats or mice was not determined in the present study, although the centrilobular hypertrophy of hepatocytes accompanied by increased liver weight was induced in the male rats and female mice fed 334.3 mg/kg/day p-CNB. The problem of whether hepatocellular hypertrophy with increased liver weight without additional adverse changes such as necrosis or nuclear atypia is an adaptive or adverse response and is secondary to the hematotoxic effects of p-CNB is a subject for future research.
It has been demonstrated with rats, rabbits and isolated rat hepatocytes that p-CNB undergoes a main metabolic pathway to 2-amino-5-chlorophenol through p-chloroaniline (Bray et al., 1956; Rickert and Held, 1990; Yoshida et al., 1991 and 1993) , while o-CNB is metabolized to 2-amino-3-chlorophenol and 3-amino-4-chlorophenol partly through the reduction of 2-nitro-3-chlorophenol and 3-nitro-4-chlorophenol and the hydroxylation of o-chloroaniline. It remains unsolved whether p-and o-CNB per se or their reactive metabolites are responsible for the differential toxicity of the two isomers. However, it is noteworthy that the oral administration of p-chloroaniline hydrochloride, a principal intermediate metabolite of p-CNB, in water by gavage to F344 rats and B6C3F 1 mice of both sexes for 13 weeks produced the same types of hematological, splenic and hepatic responses as those found in the present study, resulting from increased methemoglobin formation (NTP, 1989) . In addition, no hepatocellular Vol. 31 No. 1 lesions were found in any of the p-chloroaniline-dosed animals in the NTP study.
